Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX®) in pediatric and nonpediatric patients with bacterial conjunctivitis

Survey of Ophthalmology

Volumn 50, Issue 6 SUPPL. 1, 2005, Pages

  Silver, Lewis H ^a   Woodside, Adrienne M ^a   Montgomery, Dawnelle B ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

Adverse events; Conjunctivitis; Fluoroquinolone; Moxifloxacin; Ophthalmic; Pediatric; Safety; VIGAMOX

Indexed keywords

CIPROFLOXACIN; MOXIFLOXACIN; OFLOXACIN;

ARTICLE; BLEPHARITIS; CLINICAL TRIAL; CONJUNCTIVITIS; COUGHING; DRUG SAFETY; DRUG TOLERABILITY; EVALUATION; EYE DISEASE; EYE INFECTION; FEVER; HEADACHE; HUMAN; INCIDENCE; INFECTION; INTRAOCULAR HEMORRHAGE; KERATITIS; OTITIS MEDIA; PHARYNGITIS; PRIORITY JOURNAL; PRURITUS; RHINITIS; SIDE EFFECT; VISUAL ACUITY; VOMITING;

ADULT; AZA COMPOUNDS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; CONJUNCTIVITIS, BACTERIAL; HUMANS; INFANT; OPHTHALMIC SOLUTIONS; QUINOLINES;

EID: 27844526736     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2005.05.004     Document Type: Article

References (11)

1. J.M. Blondeau Fluoroquinolones: mechanism of action, classification, and development of resistance Surv Ophthalmol 49 Suppl 2 2004 S73 S78
2. N.A. Chaudhry, H.W. Flynn, and T.G. Murray Emerging ciprofloxacin- resistant Pseudomonas aeruginosa Am J Ophthalmol 128 1999 509 510
3. D. Church, D. Haverstock, and V.T. Andriole Moxifloxacin: a review of its safety profile based on worldwide clinical trials Todays Therapeut Trends 18 3 2000 205 233
4. M.C. Fisher Conjunctivitis in children Pediatr Clin North Am 34 1987 1447 1456
5. F. Gigliotti, J.O. Hendley, and J. Morgan Efficacy of topical antibiotic therapy in acute conjunctivitis in children J Pediatr 104 1984 623 626
6. M.H. Goldstein, R.P. Kowalski, and Y.J. Gordon Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review Ophthalmology 106 1999 1313 1318
7. R.D. Gross, R.O. Hoffman, and R.N. Lindsay A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children Clin Pediatr (Phila) 36 1997 445 448
8. R.P. Kowalski, A.N. Pandya, and L.M. Karenchak An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa Ophthalmology 108 2001 1826 1829
9. R. Mather, L.M. Karenchak, E.G. Romanowski, and R.P. Kowalski Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics Am J Ophthalmol 133 2002 463 466
10. H. Schedletzky, B. Wiedemann, and P. Heisig The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus J Antimicrob Chemother 43 1999 31 37
11. B.J. Tripathi, R.C. Tripathi, and S.P. Kolli Cytotoxicity of ophthalmic preservatives on human corneal epithelium Lens Eye Toxic Res 9 1992 361 375